CMPS

4.58 -0.17 (-3.58%)

COMPASS Pathways Plc Sponsored ADR · NASDAQ

Performance

+22.13%

1W

-1.93%

1M

-26.25%

3M

-26.13%

6M

+21.16%

YTD

-53.88%

1Y

Profile

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Technical Analysis of CMPS 2025-01-07

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 50 indicating stability, while the Oscillators and Technical Scores at 43 and 46 suggest a slight bearish inclination. Overall, the combined scores imply a cautious market outlook, warranting close monitoring for potential shifts in momentum.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of CMPS

Created with Highcharts 11.1.020201414393944440100
QualityGrowthMomentumValue4

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.